This Week's Exclusive

Hepatocellular carcinoma (HCC) is the sixth most common tumor globally. Patients with HCC have a dismal prognosis, with a 5-year survival rate of 18%. Thomas A. Abrams, MD, assistant professor of medicine at Harvard Medical School, spoke with i3 Health about how strong physician-patient relationships and a multidisciplinary approach can facilitate the management of HCC and improve outcomes.  ...

Top Oncology Stories

Friday, October 19, 2018
An extensive screening study conducted by Lund University and Skåne University Hospital (SUS) in Sweden found that 3D mammography, also called breast tomosynthesis, was able to...
Friday, October 19, 2018
​The first study of its kind to focus exclusively on black men has found that a baseline measurement of prostate-specific antigen (PSA) performed at midlife predicts the later ...
Thursday, October 18, 2018
A new cancer detection test called TumorScanTM may be the first universal liquid biopsy to be introduced into the market. Developed at the University of Bradford, the test, alon...
Thursday, October 18, 2018
​Talazoparib (Talzenna®, Pfizer Inc.), an orally available poly (ADP-ribose) polymerase (PARP) inhibitor, has been approved by the United States Food and Drug Administration (F...
Thursday, October 18, 2018
Researchers have found that levels of two inflammation-inducing proteins in the colon rise incrementally with weight, increasing an individual's risk of colon cancer.The third ...

Expert Perspectives

Metastatic breast cancer (MBC) is associated with a poor prognosis, and patients often develop refractory or resistant disease, adverse events, depression, and financial hardship. Mikel Ross, MSN, RN, AGPCNP-BC, OCN®, CBCN®, office practice nurse in ...
Based on recent estimates, kidney cancer accounts for approximately 4% of all cancer diagnoses in the United States. An estimated 65,300 new cases are reported each year and more than 14,000 people die of the disease...
Ursula Matulonis, MD Ovarian cancer accounts for 5% of cancer deaths among women in the United States and causes more deaths than any other cancer of the female reproductive system. An estimated 22,240 new cases ...
Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine tumor of unknown origin that typically presents in older white and immunocompromised adults. An estimated 1,500 cases are diagnosed in the United States an...
Hematopoietic stem cell transplant (HSCT) is a potentially curative therapy for patients with hematologic malignancies. There are 2 primary types of HSCT: autologous, where the cells are taken from the patient, and allogene...

Original Research

In order to identify the continuing medical education needs and preferences of hematology/oncology fellows, i3 Health administered a survey to participants at several live CME-certified visiting faculty meetings. i3 Health inte...
Chronic myeloid leukemia (CML) accounts for 15% of all adult leukemias and is characterized by heterogenous clinical manifestations. In recent years outcomes for patients with CML have greatly improved, in part due to the a...
Many patients with cancer who receive systemic therapy experience cancer treatment-related cognitive impairment, commonly referred to as "chemo brain." Chemo brain is characterized by the inability to remember certain thing...
The incidence of suicide among patients with cancer in the United States is twice that of the general population. Studies demonstrate that demoralization, defined as lowered morale and perceived incapacity to cope, is stron...
Chronic lymphocytic leukemia (CLL) has an extremely variable disease course, with some patients having an indolent disease that does not require treatment for many years and others presenting with an aggressive and symptoma...
© Copyright 2018 i3 Health. All rights reserved.